000 | 01254 a2200313 4500 | ||
---|---|---|---|
005 | 20250515012403.0 | ||
264 | 0 | _c20060223 | |
008 | 200602s 0 0 eng d | ||
022 | _a0008-5472 | ||
024 | 7 |
_a10.1158/0008-5472.CAN-05-2053 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKarlsson, Jan Olof G | |
245 | 0 | 0 |
_aThe magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity. _h[electronic resource] |
260 |
_bCancer research _cJan 2006 |
||
300 |
_a598; author reply 598 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aBiomimetic Materials _xpharmacology |
650 | 0 | 4 |
_aContrast Media _xpharmacology |
650 | 0 | 4 |
_aEdetic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aHydrogen Peroxide _xmetabolism |
650 | 0 | 4 |
_aPyridoxal Phosphate _xanalogs & derivatives |
650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
700 | 1 | _aBrurok, Heidi | |
700 | 1 | _aTowart, Rob | |
700 | 1 | _aJynge, Per | |
773 | 0 |
_tCancer research _gvol. 66 _gno. 1 _gp. 598; author reply 598 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-05-2053 _zAvailable from publisher's website |
999 |
_c16014828 _d16014828 |